Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
International Immunopharmacology|February 16, 2026
Inhibition of ROCK2 impedes osteoclastogenesis through Src-Ca2+-NFATc1 signaling pathway and alleviates ovariectomy-induced bone lossQin Yang, Jianchao Chen, Lihong Li, et al.Pharmacological Research|August 15, 2025
Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseasesBinhua Zou, Jiehuang Zheng, Weili He, et al.Cell Stem Cell|November 7, 2025
Tissue regeneration: Unraveling strategies for resolving pathological fibrosisJiao Li, Shuyong Wang, Jie Yuan, et al.ACS Applied Materials & Interfaces|November 20, 2024
Combination of Transfer Learning and Chemprop Interpreter with Support of Deep Learning for the Energy Levels of Organic Photovoltaic Materials Prediction and RegulationCong Nie, Kuo Wang, Haixin Zhou, et al.Biochemical Pharmacology|March 7, 2026
A resveratrol derivative RVX-208 inhibits PD-1/PD-L1 to restrain non-small cell lung cancer as an immunotherapyZiye Chen, Ruopeng Li, Fengsheng Chen, et al.Biochemical Pharmacology|February 15, 2026
An allosteric SHP2 inhibitor suppresses breast cancer-induced osteoclastogenesis and bone lysisQinghe Liang, Wenqi Dai, Jiehuang Zheng, et al.Frontiers in Medicine|June 24, 2025
Heterotaxy polysplenia syndrome with cholangiopancreatic cancer: a case report and literature reviewZiye Chen, Yu-Ann Chen, Xuedong Wang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 5, 2026
Hexahydrocurcumin inhibits osteoclastogenesis and bone destruction in osteoporosis by targeting c-SrcLihong Li, Wenqi Dai, Zhuwei Zhong, et al.Journal of Advanced Research|March 31, 2024
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destructionJiehuang Zheng, Weili He, Yan Chen, et al.Cancer Biology & Medicine|September 14, 2019
Cytosolic phospholipase A2α modulates cell-matrix adhesion via the FAK/paxillin pathway in hepatocellular carcinomaPiao Guo, Yuchao He, Lu Chen, et al.Pageof 6